Engineering cocrystal solubility, stability, and pH max by micellar solubilization
dc.contributor.author | Huang, Neal Chun | en_US |
dc.contributor.author | Rodríguez‐hornedo, Naír | en_US |
dc.date.accessioned | 2011-11-10T15:35:25Z | |
dc.date.available | 2013-02-01T20:26:16Z | en_US |
dc.date.issued | 2011-12 | en_US |
dc.identifier.citation | Huang, Neal; Rodríguez‐hornedo, Naír (2011). "Engineering cocrystal solubility, stability, and pH max by micellar solubilization." Journal of Pharmaceutical Sciences 100(12): 5219-5234. <http://hdl.handle.net/2027.42/86984> | en_US |
dc.identifier.issn | 0022-3549 | en_US |
dc.identifier.issn | 1520-6017 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/86984 | |
dc.description.abstract | Cocrystals offer great promise in enhancing drug aqueous solubilities, but face the challenge of conversion to a less soluble drug when in contact with solvent. This manuscript shows that differential solubilization of cocrystal components by micelles can impart thermodynamic stability to otherwise unstable cocrystals. The theoretical foundation for controlling cocrystal solubility and stability is presented by considering the contributions of micellar solubilization and ionization of cocrystal components. A surfactant critical stabilization concentration (CSC) and a solution pH (pH max ) where cocrystal and drug are thermodynamically stable are shown to characterize cocrystal stability in micellar solutions. The solubility, CSC, and pH max of carbamazepine cocrystals in micellar solutions of sodium lauryl sulfate predicted by the models are in very good agreement with experimental measurements. The findings from this work demonstrate that cocrystal CSC and pH max can be tailored from the selection of coformer and solubilizing additives such as surfactants, thus providing an unprecedented level of control over cocrystal stability and solubility via solution phase chemistry. © 2011 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 100:5219–5234, 2011 | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Acid–Base Equilibria | en_US |
dc.subject.other | Cocrystals | en_US |
dc.subject.other | Crystal Engineering | en_US |
dc.subject.other | Solubility | en_US |
dc.subject.other | Stabilization | en_US |
dc.subject.other | Surfactants | en_US |
dc.subject.other | Thermodynamics | en_US |
dc.subject.other | PH | en_US |
dc.subject.other | Micelle | en_US |
dc.title | Engineering cocrystal solubility, stability, and pH max by micellar solubilization | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109‐1065 | en_US |
dc.contributor.affiliationum | Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109‐1065. Telephone: +734‐763‐0101; Fax: +734‐615‐6162 | en_US |
dc.identifier.pmid | 21910122 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/86984/1/22725_ftp.pdf | |
dc.identifier.doi | 10.1002/jps.22725 | en_US |
dc.identifier.source | Journal of Pharmaceutical Sciences | en_US |
dc.identifier.citedreference | Fleischman SG, Kuduva SS, McMahon JA, Moulton B, Walsh RDB, Rodríguez‐Hornedo N, Zaworotko MJ. 2003. Crystal engineering of the composition of pharmaceutical phases: Multiple‐component crystalline solids involving carbamazepine. Cryst Growth Des 3 ( 6 ): 909 – 919. | en_US |
dc.identifier.citedreference | Childs SL, Hardcastle KI. 2007. Cocrystals of piroxicam with carboxylic acids. Cryst Growth Des 7 ( 7 ): 1291 – 1304. | en_US |
dc.identifier.citedreference | Nehm SJ, Rodríguez‐Spong B, Rodríguez‐Hornedo N. 2006. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation. Cryst Growth Des 6 ( 2 ): 592 – 600. | en_US |
dc.identifier.citedreference | Bethune SJ, Huang N, Jayasankar A, Rodríguez‐Hornedo N. 2009. Understanding and predicting the effect of cocrystal components and pH on cocrystal solubility. Cryst Growth Des 9 ( 9 ): 3976 – 3988. | en_US |
dc.identifier.citedreference | Jayasankar A, Reddy LS, Bethune SJ, Rodríguez‐Hornedo N. 2009. Role of cocrystal and solution chemistry on the formation and stability of cocrystals with different stoichiometry. Cryst Growth Des 9 ( 2 ): 889 – 897. | en_US |
dc.identifier.citedreference | Remenar JF, Peterson ML, Stephens PW, Zhang Z, Zimenkov Y, Hickey MB. 2007. Celecoxib:Nicotinamide dissociation: Using excipients to capture the cocrystal's potential. Mol Pharm 4 ( 3 ): 386 – 400. | en_US |
dc.identifier.citedreference | McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, Mannion R, O'Donnell E, Park A. 2006. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res 23 ( 8 ): 1888 – 1897. | en_US |
dc.identifier.citedreference | Yadav AV, Dabke AP, Shete AS. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride. Drug Dev Ind Pharm 36 ( 9 ): 1036 – 1045. | en_US |
dc.identifier.citedreference | Christian SD, Scamehorn JF. 1995. Solubilization in surfactant aggregates. Marcel Dekker, Inc., New York, New York. | en_US |
dc.identifier.citedreference | Strickley RG. 2004. Solubilizing excipients in oral and injectable formulations. Pharm Res 21 ( 2 ): 201 – 230. | en_US |
dc.identifier.citedreference | Wiedmann TS, Kamel L. 2002. Examination of the solubilization of drugs by bile salt micelles. J Pharm Sci 91 ( 8 ): 1743 – 1764. | en_US |
dc.identifier.citedreference | Wiedmann TS, Bhatia R, Wattenberg LW. 2000. Drug solubilization in lung surfactant. J Control Release 65 ( 1–2 ): 43 – 47. | en_US |
dc.identifier.citedreference | Serajuddin ATM, Sheen P‐C, Mufson D, Bernstein DF, Augustine MA. 1988. Physicochemical basis of increased bioavailability of a poorly water‐soluble drug following oral administration as organic solutions. J Pharm Sci 77 ( 4 ): 325 – 329. | en_US |
dc.identifier.citedreference | Serajuddin ATM. 1999. Solid dispersion of poorly water‐soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88 ( 10 ): 1058 – 1066. | en_US |
dc.identifier.citedreference | Rodríguez‐Hornedo N, Nehm SJ, Jayasankar A. 2006. Cocrystals: Design, properties and formation mechanisms. In Encyclopedia of Pharmaceutical Technology, Eds. Swarbrick and Boylan, Informa Health Care, London; 3rd ed. pp 615 – 635. | en_US |
dc.identifier.citedreference | Rodríguez‐Hornedo N, Nehm SJ, Seefeldt KF, Pagan‐Torres Y, Falkiewicz CJ. 2006. Reaction crystallization of pharmaceutical molecular complexes. Mol Pharm 3: 362 – 367. | en_US |
dc.identifier.citedreference | Bak A, Gore A, Yanez E, Stanton M, Tufekcic S, Syed R, Akrami A, Rose M, Surapaneni S, Bostick T, King A, Neervannan S, Ostovic D, Koparkar A. 2008. The co‐crystal approach to improve the exposure of a water‐insoluble compound: AMG 517 sorbic acid co‐crystal characterization and pharmacokinetics. J Pharm Sci 97 ( 9 ): 3942 – 3956. | en_US |
dc.identifier.citedreference | Schultheiss N, Newman A. 2009. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des 9 ( 6 ): 2950 – 2967. | en_US |
dc.identifier.citedreference | Huang N, Rodríguez‐Hornedo N. 2010. Effect of micellar solubilization on cocrystal solubility and stability. Cryst Growth Des 10 ( 5 ): 2050 – 2053. | en_US |
dc.identifier.citedreference | Huang N, Rodríguez‐Hornedo N. 2011. Engineering cocrystal thermodynamic stability and eutectic points by micellar solubilization and ionization. CrystEngComm 13 ( 17 ): 409 – 5422. | en_US |
dc.identifier.citedreference | Nordström FL, Rasmuson ÅC. 2006. Solubility and melting properties of salicylic acid. J Chem Eng Data 51 ( 5 ): 1668 – 1671. | en_US |
dc.identifier.citedreference | Williamson DS, Nagel DL, Markin RS, Cohen SM. 1987. Effect of pH and ions on the electronic structure of saccharin. Food Chem Toxicol 25 ( 3 ): 211 – 218. | en_US |
dc.identifier.citedreference | Kojima S, Ichigabase H, Iguchi S. 1966. Studies on sweetening agents. VII. Absorption and excretion of sodium cyclamate (2). Chem Pharm Bull 14 ( 9 ): 965 – 971. | en_US |
dc.identifier.citedreference | O'Neil M, Smith A, Heckelman P, Budavari S. 2001. The Merck Index. 13th ed. New York: John Wiley and Sons. | en_US |
dc.identifier.citedreference | Robinson RA, Biggs AI. 1957. The ionization constants of p‐aminobenzoic acid in aqueous solution at 25°C. Aust J Chem 10 ( 2 ): 128 – 134. | en_US |
dc.identifier.citedreference | Li P, Tabibi SE, Yalkowsky SH. 1998. Combined effect of complexation and pH on solubilization. J Pharm Sci 87 ( 12 ): 1535 – 1537. | en_US |
dc.identifier.citedreference | Jain A, Ran YQ, Yalkowsky SH. 2004. Effect of pH‐sodium lauryl sulfate combination on solubilization of PG‐300995 (an anti‐HIV agent): A technical note. AAPS PharmSciTech 5 ( 3 ): 65 – 67. | en_US |
dc.identifier.citedreference | He Y, Yalkowsky SH. 2006. Solubilization of monovalent weak electrolytes by micellization or complexation. Int J Pharm 314 ( 1 ): 15 – 20. | en_US |
dc.identifier.citedreference | Good DJ, Rodríguez‐Hornedo N. 2009. Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des 9 ( 5 ): 2252 – 2264. | en_US |
dc.identifier.citedreference | Bethune SJ. 2009. Thermodynamic and kinetic parameters that explain crystallization and solubility of pharmaceutical cocrystals. PhD Thesis; University of Michigan, Ann Arbor, MI. | en_US |
dc.identifier.citedreference | Good DJ, Rodríguez‐Hornedo N. 2010. Cocrystal eutectic constants and prediction of solubility behavior. Cryst Growth Des 10 ( 3 ): 1028 – 1032. | en_US |
dc.identifier.citedreference | Rodríguez‐Hornedo N, Murphy D. 2004. Surfactant‐facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph. J Pharm Sci 93 ( 2 ): 449 – 460. | en_US |
dc.identifier.citedreference | Mukerjee P, Mysels KJ. 1971. Critical micelle concentrations of aqueous surfactant systems. Washington, District of Columbia: US National Bureau of Standards. | en_US |
dc.identifier.citedreference | Crison JR, Weiner ND, Amidon GL. 1997. Dissolution media for in vitro testing of water‐insoluble drugs: Effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. J Pharm Sci 86 ( 3 ): 384 – 388. | en_US |
dc.identifier.citedreference | Seedher N, Kanojia M. 2008. Micellar solubilization of some poorly soluble antidiabetic drugs: A technical note. AAPS PharmSciTech 9 ( 2 ): 431 – 436. | en_US |
dc.identifier.citedreference | Aburub A, Risley DS, Mishra D. 2008. A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe. Int J Pharm 347 ( 1–2 ): 16 – 22. | en_US |
dc.identifier.citedreference | Moroi Y. 1992. Micelles: Theoretical and applied aspects. Plenum Press, New York, New York. | en_US |
dc.identifier.citedreference | Rangel‐Yagui CO, Junior AP, Tavares LC. 2005. Micellar solubilization of drugs. J Pharm Sci 8 ( 2 ): 147 – 163. | en_US |
dc.identifier.citedreference | Pennell KD, Adinolfi AM, Abriola LM, Diallo MS. 1997. Solubilization of dodecane, tetrachloroethylene, and 1,2‐dichlorobenzene in micellar solutions of ethoxylated nonionic surfactants. Environ Sci Technol 31 ( 5 ): 1382 – 1389. | en_US |
dc.identifier.citedreference | Stilbs P. 1983. A comparative study of micellar solubilization for combinations of surfactants and solubilizates using the Fourier transform pulsed‐gradient spin–echo NMR multicomponent self‐diffusion technique. J Colloid Interface Sci 94 ( 2 ): 463 – 469. | en_US |
dc.identifier.citedreference | Hayworth JS, Burris DR. 1997. Nonionic surfactant‐enhanced solubilization and recovery of organic contaminants from within cationic surfactant‐enhanced sorbent zones. 1. Experiments. Environ Sci Technol 31 ( 5 ): 1277 – 1283. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.